Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/0101-60830000000141 https://repositorio.unifesp.br/handle/11600/58201 |
Resumo: | Background: Recent evidence has shown improvements in schizophrenia symptoms after the infusion of sodium nitroprusside (SNP), a nitric oxide (NO) donor. In the rat model of schizophrenia using ketamine injection, pretreatment with SNP seems to prevent behavioral changes associated with positive symptoms for up to one week. Objective: We investigated whether SNP would have preventative effects on psychogenic symptoms induced by ketamine in healthy subjects. Methods: Healthy subjects (N = 38) were assigned to distinct groups that received SNP in different doses (0.15, 0.25, and 0.5 mcg/kg/min). First, participants received an infusion of SNP or placebo over 75 minutes. After 10 minutes, they were injected for 1 minute with a bolus of 0.26 mg/kg of ketamine and a maintenance dose was started 5 minutes later, with 0.25 mg/kg/h of ketamine for 50 minutes. Results: Ketamine-induced psychopathological alterations induced were reduced by SNP, as assessed with the Brief Psychological Rating Scale. Scores in the objective subscale of the Clinician-Administered Dissociative States Scale were also lower in SNP sessions compared to placebo. SNP had protective effects against deterioration in facial emotion and identity recognition tasks induced by ketamine. Discussion: Our findings support the view that SNP has preventative properties against psychotic manifestations. |
id |
UFSP_4822a28324d66f5cf6cb25d09a58aa0c |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/58201 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind studyNitric oxidesodium nitroprussideketamineschizophreniapsychosisBackground: Recent evidence has shown improvements in schizophrenia symptoms after the infusion of sodium nitroprusside (SNP), a nitric oxide (NO) donor. In the rat model of schizophrenia using ketamine injection, pretreatment with SNP seems to prevent behavioral changes associated with positive symptoms for up to one week. Objective: We investigated whether SNP would have preventative effects on psychogenic symptoms induced by ketamine in healthy subjects. Methods: Healthy subjects (N = 38) were assigned to distinct groups that received SNP in different doses (0.15, 0.25, and 0.5 mcg/kg/min). First, participants received an infusion of SNP or placebo over 75 minutes. After 10 minutes, they were injected for 1 minute with a bolus of 0.26 mg/kg of ketamine and a maintenance dose was started 5 minutes later, with 0.25 mg/kg/h of ketamine for 50 minutes. Results: Ketamine-induced psychopathological alterations induced were reduced by SNP, as assessed with the Brief Psychological Rating Scale. Scores in the objective subscale of the Clinician-Administered Dissociative States Scale were also lower in SNP sessions compared to placebo. SNP had protective effects against deterioration in facial emotion and identity recognition tasks induced by ketamine. Discussion: Our findings support the view that SNP has preventative properties against psychotic manifestations.Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci & Behav, Ribeirao Preto, SP, BrazilNatl Inst Sci & Technol Translat Med INCT TM, Fortaleza, Ceara, BrazilUniv Fed Rio Grande do Norte, Dept Clin Med, Natal, RN, BrazilFed Univ Sao Paulo Unifesp, Dept Psychiat, Sao Paulo, SP, BrazilUniv Alberta, Dept Psychiat, Neurochem Res Unit, Edmonton, AB, CanadaFed Univ Sao Paulo Unifesp, Dept Psychiat, Sao Paulo, SP, BrazilWeb of ScienceUniv Sao Paulo, Inst Psiquiatria2020-09-01T13:21:19Z2020-09-01T13:21:19Z2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion149-153application/pdfhttp://dx.doi.org/10.1590/0101-60830000000141Archives Of Clinical Psychiatry. Sao Paulo, v. 44, n. 6, p. 149-153, 2017.10.1590/0101-60830000000141S0101-60832017000600149.pdf0101-6083S0101-60832017000600149https://repositorio.unifesp.br/handle/11600/58201WOS:000419784600003engArchives Of Clinical PsychiatrySao Pauloinfo:eu-repo/semantics/openAccessRezende, Tatiana M. N.Maia-de-Oliveira, Joao PauloKandratavicius, LudmylaMachado-de-Sousa, Joao PauloAbrao, JoaoPrado, Daniel AlmeidaBressan, Rodrigo A. [UNIFESP]Lacerda, Acioly L. T. [UNIFESP]Zuardi, Antonio W.Baker, Glen B.Dursun, Serdar M.Hallak, Jaime E. C.reponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-01T22:57:41Zoai:repositorio.unifesp.br/:11600/58201Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-01T22:57:41Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study |
title |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study |
spellingShingle |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study Rezende, Tatiana M. N. Nitric oxide sodium nitroprusside ketamine schizophrenia psychosis |
title_short |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study |
title_full |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study |
title_fullStr |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study |
title_full_unstemmed |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study |
title_sort |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study |
author |
Rezende, Tatiana M. N. |
author_facet |
Rezende, Tatiana M. N. Maia-de-Oliveira, Joao Paulo Kandratavicius, Ludmyla Machado-de-Sousa, Joao Paulo Abrao, Joao Prado, Daniel Almeida Bressan, Rodrigo A. [UNIFESP] Lacerda, Acioly L. T. [UNIFESP] Zuardi, Antonio W. Baker, Glen B. Dursun, Serdar M. Hallak, Jaime E. C. |
author_role |
author |
author2 |
Maia-de-Oliveira, Joao Paulo Kandratavicius, Ludmyla Machado-de-Sousa, Joao Paulo Abrao, Joao Prado, Daniel Almeida Bressan, Rodrigo A. [UNIFESP] Lacerda, Acioly L. T. [UNIFESP] Zuardi, Antonio W. Baker, Glen B. Dursun, Serdar M. Hallak, Jaime E. C. |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Rezende, Tatiana M. N. Maia-de-Oliveira, Joao Paulo Kandratavicius, Ludmyla Machado-de-Sousa, Joao Paulo Abrao, Joao Prado, Daniel Almeida Bressan, Rodrigo A. [UNIFESP] Lacerda, Acioly L. T. [UNIFESP] Zuardi, Antonio W. Baker, Glen B. Dursun, Serdar M. Hallak, Jaime E. C. |
dc.subject.por.fl_str_mv |
Nitric oxide sodium nitroprusside ketamine schizophrenia psychosis |
topic |
Nitric oxide sodium nitroprusside ketamine schizophrenia psychosis |
description |
Background: Recent evidence has shown improvements in schizophrenia symptoms after the infusion of sodium nitroprusside (SNP), a nitric oxide (NO) donor. In the rat model of schizophrenia using ketamine injection, pretreatment with SNP seems to prevent behavioral changes associated with positive symptoms for up to one week. Objective: We investigated whether SNP would have preventative effects on psychogenic symptoms induced by ketamine in healthy subjects. Methods: Healthy subjects (N = 38) were assigned to distinct groups that received SNP in different doses (0.15, 0.25, and 0.5 mcg/kg/min). First, participants received an infusion of SNP or placebo over 75 minutes. After 10 minutes, they were injected for 1 minute with a bolus of 0.26 mg/kg of ketamine and a maintenance dose was started 5 minutes later, with 0.25 mg/kg/h of ketamine for 50 minutes. Results: Ketamine-induced psychopathological alterations induced were reduced by SNP, as assessed with the Brief Psychological Rating Scale. Scores in the objective subscale of the Clinician-Administered Dissociative States Scale were also lower in SNP sessions compared to placebo. SNP had protective effects against deterioration in facial emotion and identity recognition tasks induced by ketamine. Discussion: Our findings support the view that SNP has preventative properties against psychotic manifestations. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017 2020-09-01T13:21:19Z 2020-09-01T13:21:19Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/0101-60830000000141 Archives Of Clinical Psychiatry. Sao Paulo, v. 44, n. 6, p. 149-153, 2017. 10.1590/0101-60830000000141 S0101-60832017000600149.pdf 0101-6083 S0101-60832017000600149 https://repositorio.unifesp.br/handle/11600/58201 WOS:000419784600003 |
url |
http://dx.doi.org/10.1590/0101-60830000000141 https://repositorio.unifesp.br/handle/11600/58201 |
identifier_str_mv |
Archives Of Clinical Psychiatry. Sao Paulo, v. 44, n. 6, p. 149-153, 2017. 10.1590/0101-60830000000141 S0101-60832017000600149.pdf 0101-6083 S0101-60832017000600149 WOS:000419784600003 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Archives Of Clinical Psychiatry |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
149-153 application/pdf |
dc.coverage.none.fl_str_mv |
Sao Paulo |
dc.publisher.none.fl_str_mv |
Univ Sao Paulo, Inst Psiquiatria |
publisher.none.fl_str_mv |
Univ Sao Paulo, Inst Psiquiatria |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268451351429120 |